Search for: "Novartis Ag"
Results 261 - 280
of 440
Sorted by Relevance
|
Sort by Date
3 Nov 2010, 7:00 am
Two years later, Momenta Pharmaceuticals Inc. and its partner Sandoz, part of Novartis AG, filed. [read post]
18 May 2011, 1:11 pm
Nearly all over-the-counter manufacturers already include a dosing table with both weight and age. [read post]
12 Oct 2011, 3:46 am
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog) Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification (Patent Docs) Exelon (Rivastigmine)… [read post]
25 Apr 2013, 4:24 am
“The U.S. is seeing a dynamic of an aging population and a dramatic increase in diversity among new voters and workers,” added Visconti. [read post]
7 Aug 2007, 1:20 am
Novartis Pharmaceuticals Corp. [read post]
26 Oct 2007, 2:03 am
Court of Appeal (Civil Division) Neil Martin Ltd v HM Revenue & Customs [2007] EWCA Civ 1041 (25 October 2007) Cadogan & Anor v Sportelli & Anor [2007] EWCA Civ 1042 (25 October 2007) Boudh v Bodh [2007] EWCA Civ 1019 (25 October 2007) AA (Somalia) v SSHD [2007] EWCA Civ 1040 (25 October 2007) Kohn v Wagschal & Ors [2007] EWCA Civ 1022 (24 October 2007) Poole & Ors v HM Treasury [2007] EWCA Civ 1021 (24 October 2007) Wright & Ors, R (on the… [read post]
15 Aug 2008, 12:52 pm
The Editorial Board of SCRIPTed - A Journal of Law, Technology & Society is pleased to present its 18th issue, which addresses issues ranging from challenges in medical research governance in Korea, to pharmaceutical litigation (an assessment of the Novartis case in India), to data-protection of administrative records, to privacy in the age of sophisticated location-based technologies, to governance of the mobile communication sector in Korea and US, to a follow-up on our… [read post]
31 Dec 2019, 3:58 am
In one case, Novartis AG, a Swiss pharmaceutical company, developed “Glivec”, an anti-cancer drug. [read post]
19 Apr 2014, 8:50 am
On Good Friday, April 18, 2014, Chief Justice Roberts, denied Teva a request for a stay in the Copaxone case, noting that he was not convinced Teva had shown the "likelihood of irreparable harm" if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents.In this case, Teva, a known generic manufacturer, is in the role of proprietary drug maker, fighting the generic arm of a proprietary company… [read post]
9 Dec 2014, 3:50 am
He cited the VODKAT and Rihanna cases [Katposts here and here] which appear to suggest that case law has not actually moved very far from its original position.Next to speak was Myrtha Hurtado Rivas (Novartis AG), who gave a strategic overview of the trade mark v unfair competition position from the standpoint of a business that had to make decisions as to how -- and where -- to enforce its rights and protect its interests in the Europe of today -- and beyond. [read post]
25 Jul 2016, 1:40 pm
* Quia timet, de minimis and Novartis v Hospira: Mr Justice Arnold speeds through Napp v Dr Reddy pain disputeKatfriend Amy Crouch brings us the two decisions and developments in the Napp v Dr Reddy's and Sandoz litigation. [read post]
10 Jan 2015, 3:02 am
Some workers have hearing losses associated with age and fail to address the issue and create a potential safety concern in the workplace. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
29 Nov 2007, 2:29 pm
FDA staffers said no date for the meeting has been set.Those "other" asthma drugs to be consider at this future FDA meeting would be GSK's Advair and Foradil, made by Novartis AG (NVS) and sold in the U.S. by Schering-Plough Corp.As for the suggestion that Serevent and Advair should be recalled from the market, this idea was rejected by an FDA official and a GSK representative. [read post]
11 Oct 2007, 1:13 pm
"When it comes to children under age two there are no recommended doses on these products so it's not reasonable to claim they are safe and effective when used as directed," said Dr. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
23 Jul 2008, 5:00 am
Novartis Pharmaceuticals Corp., No. 05-5350, 2008 WL 2683047 (E.D. [read post]
16 Aug 2011, 11:35 pm
General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges ‘bio-piracy’ by… [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) - UK: EWHC dismisses Sandoz appeal against Floyd J's finding that Leo Pharma's patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) - US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) - US: Patent infringement suit filed in response to Paragraph IV… [read post]
